PS Medical has advanced the state-of-the-art in hydrocephalus valve te
chnology with the introduction of the Delta Valve. The Delta Valve is
designed upon the premise that the shunted patient should have intracr
anial pressure (ICP) maintenance within a normal range regardless of c
erebrospinal fluid (CSF) flow rate or body position. All previous valv
es have performance characteristics that are greatly influenced by the
negative hydrostatic pressure caused by the gravitational effect on t
he vertical water column in the distal catheter. This negative pressur
e influence is non-physiologic and contributes directly to overdrainag
e that can cause slit ventricles, subdural hematoma, and proximal cath
eter occlusions. The Delta Valve is the only valve that maintains a ne
ar-constant pressure gradient regardless of flow rate or patient postu
re. It automatically adjusts for increasing negative pressures in the
distal catheter by proportionally increasing its resistance to flow, t
hus nullifying the adverse effects of the hydrostatic force on intracr
anial pressures. The result is a shunt system that provides for CSF dr
ainage while allowing the patient's normal physiologic conditions to c
ontrol ICP. The early use of the Delta Valve in the treatment of hydro
cephalus may reduce the incidence of the dramatic complications associ
ated with overdrainage.